Spiral Therapeutics Announces Successful Completion of the SPT-2101 PHASE 1b/2a Clinical Trial for Meniere’s Disease, Data Presented During the 2024 AAO Annual Meeting
SOUTH SAN FRANCISCO, Calif., Sept. 30, 2024 — Spiral Therapeutics, Inc. (Spiral), a clinical-stage company focused on developing novel therapies for inner ear disorders, announced the successful completion of the Phase 1b/2a clinical trial of SPT-2101 (6% dexamethasone) in Meniere’s disease. Data review of 21 patients showed a significant reduction in vertigo frequency and severity. The study recruited […]
Spiral Therapeutics To Present At The Barany Society Meeting 2024
SOUTH SAN FRANCISCO, Calif., Aug. 21, 2024 — Spiral Therapeutics, Inc. (Spiral), a pharmaceutical company committed to developing advanced treatments for balance disorders and hearing loss, today announced that Dr. Jeffrey Sharon will present at the Barany Society Meeting 2024, taking place on Monday, August 26, 2024, in Uppsala, Sweden. Dr. Sharon, who serves as the Senior Vice President of Clinical […]
Spiral Therapeutics to Participate at the 2024 Wedbush PacGrow Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Aug. 5, 2024 — Spiral Therapeutics, Inc. (Spiral), a pharmaceutical company dedicated to developing advanced treatments for balance disorders and hearing loss, today announced that it will participate in the 2024 Wedbush PacGrow Healthcare Conference taking place August 13-14, 2024, in New York, NY. Hugo Peris, Spiral’s Founder and CEO, will participate in a panel focused […]
Spiral Therapeutics Receives Hearing Technology Innovator Award
SOUTH SAN FRANCISCO, Calif., August 30, 2023 — Spiral Therapeutics, Inc. (“Spiral”), a clinical-stage company focused on delivering therapies for inner ear disorders, today announced today that it has been recognized for its innovative Drug Delivery Platform in the fourth annual Hearing Technology Innovator Awards™. The annual awards program by Hearing Health & Technology Matters (HHTM) acknowledges technological innovation and […]
Spiral Therapeutics Announces Collaboration with the Vestibular Disorders Association (VeDA), Advancing Patient-Centric Care in Neurotology
SOUTH SAN FRANCISCO, Calif., Oct. 31, 2023 — Spiral Therapeutics, Inc. (“Spiral”), a clinical-stage pharmaceutical company leading the way in therapies for inner ear disorders, today announced a strategic partnership with the Vestibular Disorders Association (VeDA). This alliance aims to improve the lives of patients suffering from balance disorders like Meniere’s Disease through targeted outreach, collaborative patient education […]
Spiral Therapeutics Announces CEO’s Participation at the 3rd Inner Ear Disorders Therapeutics Summit in Boston, MA
SOUTH SAN FRANCISCO, Calif., Aug. 14, 2023 — Spiral Therapeutics, Inc. (“Spiral”), a clinical-stage company delivering therapies for inner ear disorders, is proud to announce the participation of its Chief Executive Officer, Hugo Peris, at the forthcoming 3rd Inner Ear Disorders Therapeutics Summit. The event is scheduled to take place from August 29-31, 2023, in […]
Spiral Therapeutics Acquires Otonomy Assets to Boost Inner Ear Disorders Pipeline and Appoints Industry Leaders to Board
SOUTH SAN FRANCISCO, Calif., March 29, 2023 — Spiral Therapeutics, Inc. (“Spiral”), a clinical-stage company focused on delivering therapies for inner ear disorders, announced today the completion of its acquisition of selected assets from Otonomy, Inc. (“Otonomy”), following the stockholder approval of Otonomy’s dissolution. The transaction includes preclinical and clinical data related to OTO-104 (OTIVIDEX), a sustained-exposure […]
Spiral Therapeutics Announces SPT-2101 Presentation at the 15th ASOHNS Congress in Brisbane, Australia
SOUTH SAN FRANCISCO, Calif., Mar. 06, 2023 — Spiral Therapeutics, Inc. (“Spiral”), a clinical-stage company delivering therapies for inner ear disorders, today announced a presentation at the upcoming 15th Asia Oceania ORL-HNS Congress, to be held March 8-12, 2023 in Brisbane, Australia. Dr. Jafri Kuthubutheen will join the session “Vestibular: Surgical vertigo” for an oral […]
Spiral Therapeutics Announces Poster Presentation at Association for Research in Otolaryngology Annual Meeting
SOUTH SAN FRANCISCO, Calif., Feb. 06, 2023 — Spiral Therapeutics, Inc. (“Spiral”), a clinical-stage company delivering therapies for inner ear disorders, today announced a presentation at the upcoming Association for Research in Otolaryngology (ARO) 46th Annual MidWinter Meeting, to be held February 11-15, 2023 in Orlando, FL. Dr. Isabel Varela-Nieto will present a poster related […]